Clinical Trials
45 trialsCAPTAIN-T2D
Sparrow Pharmaceuticals
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
Haukeland University Hospital
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
University of Wuerzburg
Adrenal Tumors - Pathogenesis and Therapy
University of Wuerzburg
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
National Institutes of Health Clinical Center (CC)
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
IMPACT-MACS
University of Texas Southwestern Medical Center
Study of Adrenal Gland Tumors
National Institutes of Health Clinical Center (CC)
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
Meyer Children's Hospital IRCCS
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Mayo Clinic
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
LINC CARE
RECORDATI GROUP
Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism
National Institutes of Health Clinical Center (CC)
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
Memorial Sloan Kettering Cancer Center
RESCUE
Sparrow Pharmaceuticals
Metyrapone for Mild Autonomous Cortisol Secretion (MACS)
Mayo Clinic
GRADIENT
Corcept Therapeutics
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
Mayo Clinic
GRACE
Corcept Therapeutics
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Crinetics Pharmaceuticals Inc.
ITACA
University of Roma La Sapienza
OPTIMAL
Imperial College London
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
IRCCS San Raffaele
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data
Seoul National University Hospital
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
LYDIA
Barts & The London NHS Trust
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
University Hospital Olomouc
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Corcept Therapeutics
CASE
Shanghai Jiao Tong University School of Medicine
Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients
Marmara University
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Novartis
A Prospective Cohort Study for Patients With Adrenal Diseases
Seoul National University Hospital
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
HRA Pharma
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
National Institutes of Health Clinical Center (CC)
Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects
Huashan Hospital
PRA
Seoul National University Hospital
ABACUS
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
PostLapAdrnl
Suez Canal University
AVS
Haukeland University Hospital
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Corcept Therapeutics
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Corcept Therapeutics
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Corcept Therapeutics
Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy
Jagiellonian University
SEISMIC
Corcept Therapeutics